Answers are grounded in this paper and cite their sources.
Purinergic signaling regulates neuronal and glial cell functions in the healthy CNS. In neurodegenerative diseases, purinergic signaling becomes dysregulated and can affect disease-associated phenotypes of glial cells. In this review, we discuss how cell-specific expression patterns of purinergic signaling components change in neurodegeneration and how dysregulated glial purinergic signaling and crosstalk may contribute to disease pathophysiology, thus bearing promising potential for the development of new therapeutical options for neurodegenerative diseases.
No takes yet. Share an insight, caveat, or question.
Pietrowski et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: